University Of Perugia
unipg.itTotal trials
53
Active
6
Phase 3
6
Total enrollment
10,931
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 0 of 0 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|
Next readouts
No upcoming readouts found.
Top conditions
- Atherosclerosis5
- Pelvic Organ Prolapse4
- Urinary Incontinence3
- Inflammation3
- Pulmonary Embolism3
- Quality of Life2
- Erectile Dysfunction2
- Venous Thromboembolism2
Frequently asked questions about University Of Perugia
- How many clinical trials does University Of Perugia have on ClinicalTrials.gov?
- University Of Perugia is listed as the lead sponsor on 53 clinical trials in ClinicalTrials.gov, 6 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University Of Perugia's trials are in Phase 3?
- 6 of University Of Perugia's trials are in Phase 3.
- What therapeutic areas does University Of Perugia focus on?
- University Of Perugia's most-studied conditions on ClinicalTrials.gov are Atherosclerosis, Pelvic Organ Prolapse, Urinary Incontinence, Inflammation, Pulmonary Embolism.